(Q33632831)

28 July 2017

1 reference

title

Leishmania-HIV interaction: immunopathogenic mechanisms (English)

1 reference

ORCID Public Data File 2021

28 July 2017

1 reference

author name string

Wolday D

1

1 reference

28 July 2017

Berhe N

2

1 reference

28 July 2017

Akuffo H

3

1 reference

28 July 2017

Britton S

4

1 reference

28 July 2017

publication date

1 May 1999

1 reference

28 July 2017

published in

Trends in Parasitology

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

182-187

1 reference

NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

The clinical challenge of the HIV epidemic in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Chemokine receptors and their crucial role in human immunodeficiency virus infection: major breakthroughs in HIV research.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

The role of mononuclear phagocytes in HTLV-III/LAV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Leishmaniasis. Public health aspects and control

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

AIDS and Leishmania infantum. New approaches for a new epidemiological problem

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Two cases of cutaneous leishmaniasis in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Infection of human monocytes with HIV-1Ba-L. Effect on accessory cell function for T-cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Human immunodeficiency virus causes mononuclear phagocyte dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Immune activation is a dominant factor in the pathogenesis of African AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Cytokines in the differentiation of Th1/Th2 CD4+ subsets in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Analysis of apoptosis and a Th1/Th2 phenotype in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Recurrent cutaneous leishmaniasis: a role for persistent parasites?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

New perspectives on a subclinical form of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Cellular and humoral immune responses in a population from the Baringo District, Kenya to Leishmania promastigote lipophosphoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Mononuclear cell subpopulations in human immunodeficiency virus (HIV)-positive versus HIV-negative patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901431-3

7 January 2021

10.1016/S0169-4758(99)01431-3

Identifiers

DOI

1 reference

28 July 2017

1 reference